FDA Approves RISEDRONATE SODIUM — Teva Pharmaceuticals USA, Inc.
# FDA Approves Teva Pharmaceuticals' Generic Risedronate Sodium Teva Pharmaceuticals USA, Inc. received FDA approval for its generic formulation of risedronate sodium, a widely-pr…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves Teva Pharmaceuticals' Generic Risedronate Sodium Teva Pharmaceuticals USA, Inc. received FDA approval for its generic formulation of risedronate sodium, a widely-pr…
On August 9, 2007, Rising filed an Abbreviated New Drug Application titled ANDA078306, a filing that signals the company's entry into the generic pharmaceutical sector. While the s…
# FDA Approves Aurobindo Pharma USA Generic Drug Application Aurobindo Pharma USA received FDA approval for ANDA 077873 on June 29, 2007, expanding the company's generic drug port…
# FDA Approves Generic Drug Application for Pharm Assoc Pharm Assoc has received FDA approval for ANDA078127, expanding its generic drug portfolio and positioning the company to c…
Sun Pharmaceutical Industries, Inc. received approval in 2007 for the vaginal formulation of Progesterone (NDA 022057), a move that likely expanded the company’s portfolio in the w…
# FDA Approves Accord Healthcare's Generic Fluorouracil Injection Accord Healthcare, Inc. has received FDA approval for its generic intravenous fluorouracil formulation (ANDA04079…
Takeda Pharmaceuticals America, Inc.'s VYVANSE (lisdexamfetamine dimesylate) received FDA approval for oral administration. The clearance allows the brand to retain its proprietary…
# FDA Approves Haleon's Orlistat (Alli) for Over-the-Counter Weight Management Haleon US Holdings LLC received FDA approval for Alli (orlistat), marking the first nonprescription …
# FDA Approves Heritage Pharma Avet's ANDA Application Heritage Pharma Avet has received FDA approval for its Abbreviated New Drug Application (ANDA077663), expanding the company'…
Strides Pharma Science Limited announced the FDA approval of its oral Oxycodone Hydrochloride generic, a move anticipated to intensify competitive pricing and drive generic market …
# FDA Approves Dr. Reddy's Laboratories' Generic Ondansetron Dr. Reddy's Laboratories Limited received FDA approval for its generic ondansetron hydrochloride oral formulation, exp…
West-Ward Pharmaceuticals Corp. secured FDA approval for its intramuscular formulation of ondansetron hydrochloride, a move that positions the company to capitalize on the competit…
West-Ward Pharmaceuticals Corp has received FDA approval for Ondansetron Hydrochloride Intramuscular Injection (ANDA 076780), strengthening the company's portfolio within the motio…
Strides Pharma announced the FDA approval of Metolazone Tablets, expanding its portfolio of cardiac and kidney care generic therapies and reinforcing its competitive position in th…
# FDA Approves Amneal Pharmaceuticals' Generic Colestipol Hydrochloride Amneal Pharmaceuticals of New York LLC received FDA approval for its generic colestipol hydrochloride oral …
# FDA Approves ANDA for Lannett Co Inc Lannett Co Inc received FDA approval for ANDA077960 on October 13, 2006, expanding its generic drug portfolio and positioning the company to…
Amneal Pharmaceuticals of New York LLC announced the approval of its abbreviated new drug application (ANDA) for hydrocodone bitartrate and acetaminophen, solidifying its presence …
Gravi Pharma announced that its generic drug has received FDA approval, a development expected to facilitate market entry and potentially generate revenue through competitive prici…
Strides Pharma Intl announced the approval of a generic drug application in January 2006. This early-stage development marked a significant step for the company in establishing its…
# FDA Approves SOLA Pharmaceuticals' Generic Cabergoline The FDA has approved SOLA Pharmaceuticals' abbreviated new drug application for generic cabergoline oral tablets, potentia…